Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q2 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.47 --0%
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -30.9%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.01), $0.04 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Occidental Petroleum releases Q2 2026 earnings considerations
- Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
